Summary
Discover our podcast session containing seven tracks on Identifying and mitigating risks in the viral vector supply chain featuring Claire Wartel, PhD, Director of Quality and Compliance at Polyplus-transfection and Ulises Villavicencio, Quality Auditor at Audentes Therapeutics.
Published: October 15, 2019
Interviewees: Claire Wartel & Ulises Villavicencio
These two experts discussed:
- Critical pain points for cell and gene therapy companies
- The importance of the quality of raw materials
- The GMP subject in a manufacturing process
- Quality requirements needed from regulatory agencies
- The complexity of the cell & gene supply chain
- Polyplus’ assets in this challenging environment
Partners:
 |
 |